Literature DB >> 23792241

Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease.

Imran Uraizee1, Susan Cheng, Chung-Lieh Hung, Anil Verma, James D Thomas, Michael R Zile, Gerard P Aurigemma, Scott D Solomon.   

Abstract

BACKGROUND: Elevated natriuretic peptide levels in asymptomatic individuals without heart failure are associated with increased risk of adverse cardiovascular outcomes and may reflect subclinical cardiac dysfunction.
METHODS: In a sample of 313 asymptomatic individuals (51% women, mean age 61 years) with hypertension and diastolic dysfunction, we examined the association of plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) with both conventional and advanced echocardiographic measures of systolic and diastolic function, including myocardial strain, using speckle-tracking-based analyses.
RESULTS: In univariate analyses, higher NT-proBNP was associated with greater left ventricular mass index (P = 0.003), left atrial volume index (P = 0.007), lateral E' velocity (P < 0.0001), E/E' ratio (P < 0.0001), peak global longitudinal systolic strain (P = 0.015), systolic strain rate (P = 0.021), and early diastolic strain rate (P < 0.0001). In multivariable analyses, NT-proBNP remained associated with measures of diastolic dysfunction, including lateral E' velocity (P = 0.013) and the E/E' ratio (P = 0.008). However, early diastolic strain rate was the echocardiographic parameter most strongly associated with NT-proBNP (P = 0.003).
CONCLUSIONS: In the setting of asymptomatic hypertensive heart disease and preserved ejection fraction, elevation in natriuretic peptide levels is predominantly associated with subclinical diastolic dysfunction.

Entities:  

Keywords:  blood pressure; diastolic function; hypertension; imaging; natriuretic peptides; speckle-tracking echocardiography; strain.

Mesh:

Substances:

Year:  2013        PMID: 23792241      PMCID: PMC3773573          DOI: 10.1093/ajh/hpt098

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  39 in total

1.  Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.

Authors:  Qihang Zhang; Jacob Moalem; James Tse; Peter M Scholz; Harvey R Weiss
Journal:  Eur J Pharmacol       Date:  2005-03-14       Impact factor: 4.432

2.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

3.  Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging.

Authors:  Brage H Amundsen; Thomas Helle-Valle; Thor Edvardsen; Hans Torp; Jonas Crosby; Erik Lyseggen; Asbjørn Støylen; Halfdan Ihlen; João A C Lima; Otto A Smiseth; Stig A Slørdahl
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

Review 4.  Natriuretic peptides.

Authors:  E R Levin; D G Gardner; W K Samson
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

5.  The progression from hypertension to congestive heart failure.

Authors:  D Levy; M G Larson; R S Vasan; W B Kannel; K K Ho
Journal:  JAMA       Date:  1996 May 22-29       Impact factor: 56.272

6.  Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal?

Authors:  H Sayama; Y Nakamura; N Saito; M Kinoshita
Journal:  Coron Artery Dis       Date:  1999-10       Impact factor: 1.439

7.  Biochemical detection of left-ventricular systolic dysfunction.

Authors:  T A McDonagh; S D Robb; D R Murdoch; J J Morton; I Ford; C E Morrison; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

8.  Influence of age and dose on the end-organ responses to atrial natriuretic peptide in humans.

Authors:  B A Clark; D Elahi; R P Shannon; J Y Wei; F H Epstein
Journal:  Am J Hypertens       Date:  1991-06       Impact factor: 2.689

9.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Torbjorn Omland; Philip A Wolf; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

Review 10.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

View more
  9 in total

1.  Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.

Authors:  Michael R Zile; Pardeep S Jhund; Catalin F Baicu; Brian L Claggett; Burkert Pieske; Adriaan A Voors; Margaret F Prescott; Victor Shi; Martin Lefkowitz; John J V McMurray; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

2.  Recent publications by ochsner authors: october 2013 - march 2014.

Authors: 
Journal:  Ochsner J       Date:  2014

Review 3.  Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction.

Authors:  Gilman D Plitt; Jordan T Spring; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-07-16

4.  Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.

Authors:  Sheng Jin; Xu Teng; Lin Xiao; Hongmei Xue; Qi Guo; Xiaocui Duan; Yuhong Chen; Yuming Wu
Journal:  Exp Biol Med (Maywood)       Date:  2017-10-03

5.  Association of Global Longitudinal Strain With Clinical Status and Mortality in Patients With Chronic Heart Failure.

Authors:  Sven-Oliver Tröbs; Jürgen H Prochaska; Sören Schwuchow-Thonke; Andreas Schulz; Felix Müller; Marc William Heidorn; Sebastian Göbel; Simon Diestelmeier; Jaume Lerma Monteverde; Karl J Lackner; Tommaso Gori; Thomas Münzel; Philipp S Wild
Journal:  JAMA Cardiol       Date:  2021-04-01       Impact factor: 30.154

6.  Association of Longitudinal Changes in NT-proBNP With Changes in Left Atrial Volume and Function: MESA.

Authors:  Vinithra Varadarajan; Bharath Ambale-Venkatesh; Seo Young Hong; Mohammadali Habibi; Hiroshi Ashikaga; Colin O Wu; Lin Y Chen; Susan R Heckbert; David A Bluemke; Joao A C Lima
Journal:  Am J Hypertens       Date:  2021-06-22       Impact factor: 3.080

7.  Left Ventricular Strain: A Reliable Predictor of Short-Term Outcomes in Patients with Anterior Wall Myocardial Infarction without Heart Failure.

Authors:  Bonnie R K Singh; Rishi Sethi; Nirdesh Jain; Gaurav Chaudhry; Mahim Saran; Omkar Mishra; Akshyaya Pradhan
Journal:  Adv Biomed Res       Date:  2020-11-28

8.  Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure.

Authors:  F Gaborit; H Bosselmann; N Tønder; K Iversen; T Kümler; C Kistorp; G Sölétormos; J P Goetze; M Schou
Journal:  BMC Cardiovasc Disord       Date:  2015-08-20       Impact factor: 2.298

9.  The Relation Between Global Longitudinal Strain and Serum Natriuretic Peptide Is More Strict Than That Found Between the Latter and Left Ventricular Ejection Fraction: A Retrospective Study in Chronic Heart Failure.

Authors:  Renato De Vecchis; Cesare Baldi; Giuseppina Di Biase
Journal:  J Clin Med Res       Date:  2015-10-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.